Search research articles
Contact Us
Filters
Showing results (111-120 of 205) with videos related to
Page
of 21
Sort By:
British Journal of Cancer
|
March 14, 2018
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression
Barbara J McClure, Susan L Heatley, Chung H Kok, et al.
Blood
|
April 7, 2006
OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib
Deborah L White, Verity A Saunders, Phuong Dang, et al.
Haematologica
|
August 11, 2018
Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia
Timothy P Hughes, Pierre Laneuville, Philippe Rousselot, et al.
Frontiers in Cell and Developmental Biology
|
May 17, 2021
Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells
Marc García-Montolio, Cecilia Ballaré, Enrique Blanco, et al.
British Journal of Haematology
|
April 1, 2020
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries
Anna Turkina, Jianxiang Wang, Vikram Mathews, et al.
Blood Advances
|
May 26, 2019
Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib
Chung H Kok, David T Yeung, Liu Lu, et al.
Blood Cancer Journal
|
April 21, 2022
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
Shady Adnan Awad, Oscar Brück, Naranie Shanmuganathan, et al.
Blood
|
May 3, 2002
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation
Charles G Mullighan, Sue Heatley, Kathleen Doherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications
Devendra K Hiwase, Verity Saunders, Duncan Hewett, et al.
British Journal of Haematology
|
May 1, 2020
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells
Yazad D Irani, Amy Hughes, Jade Clarson, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 205) with videos related to
Sort By:
Page
of 21
British Journal of Cancer
|
March 14, 2018
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression
Barbara J McClure, Susan L Heatley, Chung H Kok, et al.
Blood
|
April 7, 2006
OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib
Deborah L White, Verity A Saunders, Phuong Dang, et al.
Haematologica
|
August 11, 2018
Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia
Timothy P Hughes, Pierre Laneuville, Philippe Rousselot, et al.
Frontiers in Cell and Developmental Biology
|
May 17, 2021
Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells
Marc García-Montolio, Cecilia Ballaré, Enrique Blanco, et al.
British Journal of Haematology
|
April 1, 2020
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries
Anna Turkina, Jianxiang Wang, Vikram Mathews, et al.
Blood Advances
|
May 26, 2019
Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib
Chung H Kok, David T Yeung, Liu Lu, et al.
Blood Cancer Journal
|
April 21, 2022
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
Shady Adnan Awad, Oscar Brück, Naranie Shanmuganathan, et al.
Blood
|
May 3, 2002
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation
Charles G Mullighan, Sue Heatley, Kathleen Doherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications
Devendra K Hiwase, Verity Saunders, Duncan Hewett, et al.
British Journal of Haematology
|
May 1, 2020
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells
Yazad D Irani, Amy Hughes, Jade Clarson, et al.
Page
of 21